Recently Published

Recently Published Articles

Read online first articles published in JADPRO. These articles have been peer-reviewed, copyedited, and proofread by the editorial team and reviewed by the author in their final format. Each article published online first is citable via the digital object identifier (DOI) url.

Grand Rounds

Beyond Standard Endocrine Therapy: A New Adjuvant Treatment in High-Risk Early Breast Cancer

Barbara Dean, DMSc, PA-C, DFAAPA

Review Article

Diversity, Equity, and Inclusion in Multiple Myeloma: A Call to Action

Rebecca Lu,(1) MSN, FNP-C, Joseph D. Tariman,(2) PhD, MBA, ANP-BC, FAAN, Donna Catamero,(3) ANP-BC, OCN, CCRC, Michaela Hillengass,(4) RN, CPT, ACSM, and Kimberly Noonan,(5) DNP, ANP-BC, AOCN®

Translating Research Into Practice

A Real-World Evidence Primer for Advanced Practice Providers: Integrating P-Reality X Into Shared Decision-Making for People With HR+/HER2− Metastatic Breast Cancer

Sarah Donahue,(1) MPH, NP, Joanne C. Ryan,(2) PhD, RN, and Kimberly Podsada,(3) MSN, NP-C

Research and Scholarship

Evaluating the User-Perceived Benefit of a Virtual Lung Cancer Patient Education and Support Community: LVNG With Lung Cancer

Mona L. Martin,(1) RN, MPA, Kristin Bucklen,(2) BS, MBA, Lise J. Hall,(3) BA, MBA, Dann Wonser,(4) MA, LPC, Genevieve de Renne,(4) MA, OTR/L, FAOTA, and Beth Sandy,(5) MSN

Research and Scholarship

Impact of an Oncology Clinical Pharmacist Intervention on Clinical Trial Enrollment in The US Oncology Network’s MYLUNG Consortium

Elizabeth Koselke,(1), Lisa C. Kaspin-Powell,(2), Shannon Hough,(1), Joshua Howell,(1), Nicholas J. Robert,(2), Marcus A. Neubauer,(3), Susie A. Bullock,(4), Jennifer M. Walberg,(4), Melissa Rammage,(5), James E. Butrynski,(6), David Hakimian,(7), Robert M. Jotte,(8), Michael W. Meshad,(9), Kashif Ali,(10), David Michael Waterhouse,(11), Robert L. Coleman,(4), and Makenzi Colleen Evangelist,(12)

Prescriber's Corner

Advances in Myelofibrosis Management: New Janus Kinase Inhibitors Beyond Ruxolitinib

Justin Arnall,(1) PharmD, BCOP, Lindsey Lyle,(2) MS, PA-C, and Donald C. Moore,(3) PharmD, BCPS, BCOP, DPLA, FCCP

Review Article

How Can Oncology Nurses and Advanced Practice Providers Reduce the Burden of Chemotherapy-Induced Febrile Neutropenia in the US?

Kristi Kay Orbaugh,(1) MSN, NP, AOCNP®, Sandra Cuellar,(2) PharmD, BCOP, FHOPA, FASHP, and Lisa Kennedy Sheldon,(2,3,4) PhD, APRN-BC, AOCNP®, FAAN

Research and Scholarship

The Effect of Pelvic Floor Rehabilitation on Low Anterior Resection Syndrome After Colorectal Cancer Treatment

Shelby Jones,(1,2) DNP, CCRN, Alison Edie,(2) DNP, Emily Troop,(1) DPT, Joshua S. Hill,(1) MD, and Julie A. Thompson,(2) PhD

Review Article

Peripheral T-Cell Lymphoma, Not Otherwise Specified: Diagnosis and Therapeutic Approaches for the Advanced Practice Provider

Karla V. Ow, MSN, APRN, AOCNP®, Ann Vo, MSN, APRN, FNP, and Jonathan Cunningham, MPAS, PA-C

Research and Scholarship

Fostering Oral Chemotherapy Understanding and Safety (FOCUS) Project: Interventions for Improving Knowledge and Compliance With National Safety Standards

Jessica MacIntyre,(1,2) DNP, MBA, APRN, NP-C, AOCNP®, Rita D’Aoust,(1) PhD, MS, RN,  Deborah Baker,(1) DNP, CRNP, NEA-BC, Ginger Hanson,(1) PhD, MS,  Lauren Gjolaj,(2) RN, MBA, Lawrence Negret,(2) MD, and Daniel O’Neil,(3) MD

Review Article

Practical Management of Adverse Events Associated With FGFR Inhibitors for Cholangiocarcinoma for the Advanced Practice Provider

Gabriel Schwartz,(1) MSN, FNP-BC, AOCNP®, and Julianne O. Darling,(2) PharmD, BCOP

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.